Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage
Abstract Background The use of quality injectable oxytocin effectively prevents and treats postpartum hemorrhage, the leading cause of maternal death worldwide. In low- and middle-income countries (LMICs), characteristics of oxytocin—specifically its heat sensitivity—challenge efforts to ensure its...
Main Authors: | Peter Lambert, Michelle P McIntosh, Mariana Widmer, Lawrence Evans, Megan Rauscher, Rutendo Kuwana, Fiona Theunissen, Beth Yeager, Helen Petach |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Online Access: | http://link.springer.com/article/10.1186/s40545-020-00205-7 |
Similar Items
-
Prevention of Postpartum Hemorrhage with Oxytocin versus Ergometrine Plus Oxytocin in the third stage of labor
by: Thitipun Nuamsiri, et al.
Published: (2016-06-01) -
INTRAMUSCULAR OXYTOCIN SHOULD IT BE INJECTED AS ROUTINE TO CONTROL POSTPARTUM HEMORRHAGE?
by: Mooshkbid Haghighi, M, et al.
Published: (2001-01-01) -
Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
by: Minoo Rajaei, et al.
Published: (2014-01-01) -
Sublingual misoprostol versus intravenous oxytocin in the management of postpartum hemorrhage
by: Beigi A, et al.
Published: (2009-11-01) -
A comparative study on infusion of usual dose of oxytocin and 80 units dose of oxytocin in the prevention of postpartum hemorrhage in cesarean section
by: Fatemeh Ahmadi
Published: (2018-01-01)